Yummy or too sour? Arbutus Biopharma Corp (ABUS) Stock

Jefferies raised the price target for the Arbutus Biopharma Corp (NASDAQ:ABUS) stock from “a Hold” to “a Buy”. The rating was released on February 02, 2022, according to finviz. The research report from H.C. Wainwright has initiated the stock to Buy, with a price target set at $10. The stock was resumed by JMP Securities, […]

Is Arbutus Biopharma Corp (ABUS) Stock A Better Investment Than Its Rivals?

Jefferies raised the price target for the Arbutus Biopharma Corp (NASDAQ:ABUS) stock from “a Hold” to “a Buy”. The rating was released on February 02, 2022, according to finviz. The research report from H.C. Wainwright has initiated the stock to Buy, with a price target set at $10. The stock was resumed by JMP Securities, […]

Arbutus Biopharma Corp (ABUS) Stock Has More Upside Than Fundamentals Suggest

Jefferies raised the price target for the Arbutus Biopharma Corp (NASDAQ:ABUS) stock from “a Hold” to “a Buy”. The rating was released on February 02, 2022, according to finviz. The research report from H.C. Wainwright has initiated the stock to Buy, with a price target set at $10. The stock was resumed by JMP Securities, […]

Can Arbutus Biopharma Corp (ABUS) Stock rise from its doldrums?

Jefferies raised the price target for the Arbutus Biopharma Corp (NASDAQ:ABUS) stock from “a Hold” to “a Buy”. The rating was released on February 02, 2022, according to finviz. The research report from H.C. Wainwright has initiated the stock to Buy, with a price target set at $10. The stock was resumed by JMP Securities, […]

Getting Ready for the Bounce: Arbutus Biopharma Corp (ABUS) Stock

Jefferies raised the price target for the Arbutus Biopharma Corp (NASDAQ:ABUS) stock from “a Hold” to “a Buy”. The rating was released on February 02, 2022, according to finviz. The research report from H.C. Wainwright has initiated the stock to Buy, with a price target set at $10. The stock was resumed by JMP Securities, […]

A healthy upside potential exists for Arbutus Biopharma Corp (ABUS) Stock

Jefferies raised the price target for the Arbutus Biopharma Corp (NASDAQ:ABUS) stock from “a Hold” to “a Buy”. The rating was released on February 02, 2022, according to finviz. The research report from H.C. Wainwright has initiated the stock to Buy, with a price target set at $10. The stock was resumed by JMP Securities, […]

Arbutus Biopharma Corp (ABUS) Stock is the one stock you should own forever

Jefferies raised the price target for the Arbutus Biopharma Corp (NASDAQ:ABUS) stock from “a Hold” to “a Buy”. The rating was released on February 02, 2022, according to finviz. The research report from H.C. Wainwright has initiated the stock to Buy, with a price target set at $10. The stock was resumed by JMP Securities, […]